|
127
|
313
|
5skfA |
Crystal structure of human phosphodiesterase 10 in complex with 3-[5-[1-(2,2-difluoro-1,3-benzodioxol-4-yl)-4-oxopyridazin-3-yl]pyrazol-1-yl]benzonitrile |
|
123
|
313
|
5skrA |
Crystal structure of human phosphodiesterase 10 in complex with 1-methyl-n-(2-methyl-5-pyridin-2-ylpyrazol-3-yl)-4-pyridin-4-ylpyrazole-3-carboxamide |
|
123
|
313
|
5skvA |
Crystal structure of human phosphodiesterase 10 in complex with 6-cyclopropyl-n-[3-[(2-hydroxy-2-methylpropyl)carbamoyl]-1-methylpyrazol-4-yl]-3-(pyrimidin-5-ylamino)pyridine-2-carboxamide |
|
130
|
313
|
5skqA |
Crystal structure of human phosphodiesterase 10 in complex with n-ethyl-6-(4-fluorophenyl)sulfanyl-n-methyl-9h-purin-2-amine |
|
120
|
313
|
5skeA |
Crystal structure of human phosphodiesterase 10 in complex with 2-tert-butyl-5-(pyrimidin-5-ylamino)-n-[3-(trifluoromethoxy)phenyl]pyrimidine-4-carboxamide |
|
126
|
314
|
5skpA |
Crystal structure of human phosphodiesterase 10 in complex with [4-(2-methoxyphenyl)piperazin-1-yl]-(3-methyl-1-phenylthieno[2,3-c]pyrazol-5-yl)methanone |
|
125
|
314
|
5setA |
Crystal structure of human phosphodiesterase 10 in complex with 6-cyclopropyl-n-(2-methyl-5-pyridin-2-ylpyrazol-3-yl)-3-(pyrimidin-5-ylamino)pyridine-2-carboxamide |
|
126
|
313
|
5sijA |
Crystal structure of human phosphodiesterase 10 in complex with 5,8-dimethyl-2-[2-(1-methyl-4-phenylimidazol-2-yl)ethyl]-[1,2,4]triazolo[1,5-a]pyrazine |
|
122
|
313
|
5sfhA |
Crystal structure of human phosphodiesterase 10 in complex with n-cyclopropyl-5-[2-(5,8-dimethyl-[1,2,4]triazolo[1,5-a]pyrazin-2-yl)ethyl]-n,1-dimethyl-1,2,4-triazol-3-amine |
|
123
|
313
|
5sejA |
Crystal structure of human phosphodiesterase 10 in complex with 6-chloro-2-[2-(2-methyl-5-pyrrolidin-1-yl-1,2,4-triazol-3-yl)ethyl]-[1,2,4]triazolo[1,5-a]pyridine |
|
124
|
314
|
5silA |
Crystal structure of human phosphodiesterase 10 in complex with 4-chloro-n-[2-(3,5-dimethylphenyl)-1h-benzimidazol-5-yl]-2-methylpyrazole-3-carboxamide |
|
126
|
313
|
5selA |
Crystal structure of human phosphodiesterase 10 in complex with 4-(azetidine-1-carbonyl)-2-methyl-n-(2-methyl-5-pyridin-2-ylpyrazol-3-yl)pyrazole-3-carboxamide |
|
125
|
313
|
5sezA |
Crystal structure of human phosphodiesterase 10 in complex with 2-chloro-6-ethyl-n-(2-phenyl-[1,2,4]triazolo[1,5-a]pyridin-7-yl)pyridine-4-carboxamide |
|
125
|
313
|
5sf0A |
Crystal structure of human phosphodiesterase 10 in complex with 4-(azetidine-1-carbonyl)-2-methyl-n-(3-pyridin-2-yl-1h-pyrazol-5-yl)pyrazole-3-carboxamide |
|
125
|
313
|
5secA |
Crystal structure of human phosphodiesterase 10 in complex with 2-[2-(1,4-diphenylimidazol-2-yl)ethyl]-3-methylquinoxaline |
|
125
|
313
|
5shwA |
Crystal structure of human phosphodiesterase 10 in complex with (2-phenyl-[1,2,4]triazolo[1,5-a]pyridin-7-yl)methanol |
|
124
|
313
|
5sh8A |
Crystal structure of human phosphodiesterase 10 in complex with 6-methyl-n-(5-methyl-2-phenylpyrazol-3-yl)-3-(pyrimidin-5-ylamino)pyridine-2-carboxamide |
|
128
|
313
|
5sfuA |
Crystal structure of human phosphodiesterase 10 in complex with 6-cyclopropyl-3-(pyrimidin-5-ylamino)-n-[4-(pyrrolidine-1-carbonyl)pyridin-3-yl]pyridine-2-carboxamide |
|
127
|
313
|
5sh2A |
Crystal structure of human phosphodiesterase 10 in complex with 4-(azetidine-1-carbonyl)-2-methyl-n-(2-morpholin-4-yl-1,3-benzothiazol-5-yl)pyrazole-3-carboxamide |
|
123
|
313
|
5sg8A |
Crystal structure of human phosphodiesterase 10 in complex with 5-butoxy-4-ethoxypyrimidin-2-amine |
|
124
|
312
|
5sfyA |
Crystal structure of human phosphodiesterase 10 in complex with 5,8-dimethyl-2-[(e)-2-[2-methyl-5-(1h-pyrazol-4-yl)-1,2,4-triazol-3-yl]ethenyl]-[1,2,4]triazolo[1,5-a]pyrazine |
|
126
|
313
|
5sgcA |
Crystal structure of human phosphodiesterase 10 in complex with 4-(azetidine-1-carbonyl)-2-methyl-n-(2-morpholin-4-yl-[1,2,4]triazolo[1,5-c]pyrimidin-7-yl)pyrazole-3-carboxamide |
|
129
|
316
|
5sgoA |
Crystal structure of human phosphodiesterase 10 in complex with n-[3-[3-[5-(4-fluorophenyl)thieno[2,3-d]pyrimidin-4-yl]oxypropoxy]phenyl]acetamide |
|
123
|
312
|
5sfiA |
Crystal structure of human phosphodiesterase 10 in complex with 5,8-dimethyl-2-[2-[2-methyl-5-(2-methylpyrrolidin-1-yl)-1,2,4-triazol-3-yl]ethyl]-[1,2,4]triazolo[1,5-a]pyrazine |
|
123
|
313
|
5sffA |
Crystal structure of human phosphodiesterase 10 in complex with [2-methyl-6-[2-(1-methyl-4-phenylimidazol-2-yl)ethynyl]imidazo[1,2-b]pyridazin-3-yl]methanol |
|
121
|
313
|
5sgjA |
Crystal structure of human phosphodiesterase 10 in complex with 6-[(3,6-dimethylpyridine-2-carbonyl)amino]-n-methyl-2-phenyl-3h-benzimidazole-5-carboxamide |
|
126
|
313
|
5sgwA |
Crystal structure of human phosphodiesterase 10 in complex with 2-phenyl-6-(2-phenylpyrazol-3-yl)-3,4-dihydropyridazin-5-one |
|
126
|
313
|
5shbA |
Crystal structure of human phosphodiesterase 10 in complex with 3-[2-(3-bromophenyl)pyrazol-3-yl]-1-pyridin-4-ylpyridazin-4-one |
|
126
|
313
|
5sfnA |
Crystal structure of human phosphodiesterase 10 in complex with 4-(azetidine-1-carbonyl)-2-methyl-n-[2-(1-methylbenzimidazol-2-yl)ethyl]pyrazole-3-carboxamide |
|
125
|
313
|
5sk2A |
Crystal structure of human phosphodiesterase 10 in complex with 2-(4-fluorophenyl)-4-(2-isoquinolin-3-yloxyethyl)-5-methyl-1,3-oxazole |
|
122
|
315
|
5sk8A |
Crystal structure of human phosphodiesterase 10 in complex with 4-chloro-n-(2-phenyl-1h-benzimidazol-5-yl)-2-propylpyrazole-3-carboxamide |
|
118
|
312
|
5sjnA |
Crystal structure of human phosphodiesterase 10 in complex with 6,8-dichloro-2-[2-(6,7-dimethyl-1h-benzimidazol-2-yl)ethyl]-5-methyl-[1,2,4]triazolo[1,5-a]pyridine |
|
82
|
305
|
7mauA |
Sars-cov-2 main protease (mpro) in complex with covalent inhibitor dffr-yne |
|
125
|
313
|
5sk3A |
Crystal structure of human phosphodiesterase 10 in complex with [2-cyclopropyl-6-[2-(1-methyl-4-phenylimidazol-2-yl)ethyl]imidazo[1,2-b]pyridazin-3-yl]methanol |
|
124
|
314
|
5sjyA |
Crystal structure of human phosphodiesterase 10 in complex with 4-bromo-2,5-dimethyl-n-(2-phenylimidazo[1,2-a]pyrimidin-7-yl)pyrazole-3-carboxamide |
|
122
|
313
|
5sibA |
Crystal structure of human phosphodiesterase 10 in complex with 3-methyl-6-[2-(2-methyl-5-pyrrolidin-1-yl-1,2,4-triazol-3-yl)ethyl]-2-(trifluoromethyl)imidazo[1,2-b]pyridazine |
|
122
|
313
|
5shiA |
Crystal structure of human phosphodiesterase 10 in complex with 2,3,5-trimethyl-6-[2-(1-methyl-4-phenylimidazol-2-yl)ethyl]imidazo[1,2-a]pyridine |
|
125
|
313
|
5sirA |
Crystal structure of human phosphodiesterase 10 in complex with 3,6-dimethyl-n-(2-phenylimidazo[1,2-a]pyrimidin-7-yl)pyridine-2-carboxamide |
|
124
|
313
|
5sieA |
Crystal structure of human phosphodiesterase 10 in complex with 5-chloro-8-hydroxy-2-methyl-1,4-dihydropyrrolo[3,4-b]indol-3-one |
|
129
|
313
|
5sdwA |
Crystal structure of human phosphodiesterase 10 in complex with 4-n,4-n,2-trimethyl-3-n-(2-phenyl-1h-benzimidazol-5-yl)pyrazole-3,4-dicarboxamide |
|
121
|
315
|
5sdyA |
Crystal structure of human phosphodiesterase 10 in complex with 6-cyclopropyl-n-[5-(dimethylcarbamoyl)-1-(2-methoxyethyl)pyrazol-4-yl]-3-(pyrimidin-5-ylamino)pyridine-2-carboxamide |
|
125
|
313
|
5sgtA |
Crystal structure of human phosphodiesterase 10 in complex with 2-[2-[3-(4-methoxyphenyl)-4-oxoquinazolin-2-yl]ethyl]isoindole-1,3-dione |
|
128
|
313
|
5sfoA |
Crystal structure of human phosphodiesterase 10 in complex with 4-(azetidine-1-carbonyl)-2-methyl-n-[2-(1-methyl-4-phenylimidazol-2-yl)ethyl]pyrazole-3-carboxamide |
|
128
|
313
|
5sj0A |
Crystal structure of human phosphodiesterase 10 in complex with n-cyclohexyl-n-methyl-9h-purin-6-amine |
|
124
|
313
|
5sjzA |
Crystal structure of human phosphodiesterase 10 in complex with 2-methyl-4-(morpholine-4-carbonyl)-n-(2-pyrrolidin-1-yl-[1,2,4]triazolo[1,5-a]pyridin-7-yl)pyrazole-3-carboxamide |
|
126
|
313
|
5sjmA |
Crystal structure of human phosphodiesterase 10 in complex with 3-(2-phenylethyl)-5-pyridin-4-yl-1h-pyridin-2-one |
|
125
|
317
|
5sglA |
Crystal structure of human phosphodiesterase 10 in complex with n-[(e)-(4-bromo-3,5-dimethoxyphenyl)methylideneamino]-2-ethoxy-2-(4-pyrazol-1-ylphenyl)acetamide |
|
125
|
313
|
5sfcA |
Crystal structure of human phosphodiesterase 10 in complex with |
|
123
|
313
|
5sh4A |
Crystal structure of human phosphodiesterase 10 in complex with 6-[(5-methoxy-3,4,6-trimethylpyridin-2-yl)methylsulfanyl]-5h-[1,3]dioxolo[4,5-f]benzimidazole |
|
83
|
305
|
7mawA |
Sars-cov-2 main protease (mpro) in complex with covalent inhibitor sm129 |
